Transferred Patents. (i) The Company shall prepare, execute, deliver and file any and all agreements, documents or instruments which are necessary to enable Buyer to (A) prosecute and maintain the Transferred Patents in accordance with the terms of the License Agreement to the extent that the Company has the right to prosecute and maintain such Transferred Patents; and (B) defend or assert such Transferred Patents against commercially significant infringement or interference by any other Persons, and against any claims of invalidity or unenforceability, in any jurisdiction, in each case, in accordance with the terms of the License Agreement (including by bringing any legal action for infringement or defending any counterclaim of invalidity or action of a third party for declaratory judgment of non-infringement or non-interference), solely to the extent that the Company has the right to do so.
Transferred Patents. 5 Section 1.34 TWG ...............................................................5
Transferred Patents. Internal Title Ctry Current Status Filing Filing Number Grant Number Alfalfa Variety 53V52 US Grant 20 Sep 2006 11/533383 7652195 Alfalfa Variety 05N16PY US Grant 04 Oct 2011 13/252674 8461420 Alfalfa Variety 06N02PX US Grant 04 Oct 2011 13/252692 8471103 Alfalfa Variety 07W01CZ US Grant 04 Oct 2011 13/252706 8466343 Alfalfa Variety 09W08PY US In prosecution 30 Jul 2013 13/953807 Alfalfa Variety 55Q27 US Grant 06 Mar 2012 13/413254 8802930 Alfalfa Variety 09N12CY US Allowed 06 Mar 2012 13/413267 8822760 Title Application No. Filing Date Alfalfa Variety 10XXP11 62095258 12/22/2014 Alfalfa Variety 54Q14 62095279 12/22/2014 Alfalfa Variety 12XXP13 62095286 12/22/2014 Transferred Germplasm: Genetic material contained in the parent and research Product seed and the Inventory Seed (other than, in any events, any of the Excluded Seed) at the Arlington Plant Site, Nampa Plant Site or the Leased Premises. All capitalized terms shall have the meanings ascribed thereto in the Asset Purchase and Sale Agreement by and between Pioneer Lender and Borrower dated December 19, 2014. Excluding from the foregoing, any genetic material, germplasm or seed excluded pursuant to Exhibit 2.1(a)(viii) of the Asset Purchase and Sale Agreement by and between Pioneer Lender and Borrower dated December 19, 2014. Transferred PVPs: Country App_num App_date Grant # Grant start endtype den_final title holder AR 003195 9/22/1993 000677 11/3/1994 Granted 5472 PHI AR 003795 3/31/1995 000771 10/24/1995 Granted 5939 XXX XX 000000 4/9/1996 000872 2/28/1997 Granted 5681 PHI AR 005649 2/6/1998 001087 5/26/1998 Granted 58N58 PHI AR 007689 10/25/2001 001612 10/24/2002 Granted 59N49 PHI AR 008687 001982 3/15/2005 Granted 56S82 PHI AU 2003333 11/26/2003 4652 9/18/2013 Granted 57Q75 PHI AU 2005001 1/6/2005 Not yet granted Applied 56S82 PHI QZ (EP) 20112119 9/5/2011 Not yet granted Applied PR55V48 PHI QZ (EP) 20082160 10/2/2008 33444 9/24/2012 Granted PR59N59 PHI US 9100158 3/28/1991 9100158 8/31/1995 Granted 5888 PHI US 9200218 6/22/1992 9200218 8/31/1995 Granted 5454 PHI US 9200220 6/22/1992 9200220 8/31/1995 Granted 5246 PHI US 9500089 2/10/1995 9500089 3/31/1997 Granted 5312 PHI US 9600331 8/13/1996 9600331 6/30/1999 Granted Superba PHI US 9600332 8/13/1996 9600332 7/30/1999 Granted 5681 PHI US 9600333 8/13/1996 9600333 6/30/1999 Granted 5939 PHI US 9800114 2/18/1998 9800114 4/24/2001 Granted 5347LH PHI US 9800143 3/3/1998 9800143 4/24/2001 Granted 53Q60 PHI US 9800341 7/13/1998 9800341 4/24/2001 Gra...
Transferred Patents. (a) No more than forty-five (45) days after the date hereof, the Seller and the Buyer shall determine the list of Transferred Patents pursuant to the selection process described on Schedule 5.16(a)(i) of the Disclosure Schedules. Such selection process shall be conducted only with respect to the Patents listed on Schedule 5.16(a)(ii) of the Disclosure Schedules (the “Eligible Patents”), together with any “family” members. Patents will be selected by “family,” which means that Patents will be selected as a group together with any Patents that claim priority from or share priority with such listed Patents and any Patents terminally disclaimed from or to any such Patents. The Eligible Patents selected by the Buyer pursuant to such process shall be listed on Schedule 2.1(c)(i) of the Disclosure Schedules and shall be the Transferred Patents. The Eligible Patents selected by the Seller pursuant to such process shall be listed on Schedule 2.2(m) of the Disclosure Schedules and shall be Excluded Assets, and shall be Marvell Retained Patents for purposes of the Intellectual Property Agreement. In no event shall the Transferred Patents constitute more than fifty percent (50%) of the Patent families included on the list of Eligible Patents.
Transferred Patents. 5 SECTION 1.34 TWG..................................................................................5
Transferred Patents. Patent Ref. Patent No. Current Owner(s) Jurisdiction Issuance Date [ ] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. SCHEDULE 2.01(c) TRANSFERRED TRADEMARKS None. SCHEDULE 2.01(d) TRANSFERRED COPYRIGHTS None. SCHEDULE 2.01(e) TRANSFERRED INTERNET DOMAIN NAMES None. SCHEDULE 2.01(f) TRANSFERRED GOVERNMENTAL AUTHORIZATIONS Country Competent Authority Subject Date of Decision [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. SCHEDULE 2.01(i) TRANSFERRED CONTRACTS [***] [***] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Transferred Patents. Subject to the terms and conditions of this Agreement, the Purchaser hereby grants to the Seller and its Affiliates a worldwide, nonexclusive, nontransferable (except to the extent permitted in Section 6.7), irrevocable, royalty-free and fully-paid license (with the right to sublicense solely to the extent permitted in Section 2.3), under the Transferred Patents, to (a) use, make, have made (solely for the Seller or an Affiliate of the Seller), import, sell, offer for sale, and otherwise dispose of, current or future Seller Products in the Seller Field of Use; and (b) practice any methods for the purpose of using, making, having made (solely for the Seller or an Affiliate of the Seller), importing, selling, offering for sale, or otherwise disposing of, current or future Seller Products in the Seller Field of Use. This license will remain in effect until the expiration of the last-to-expire of the Transferred Patents.
Transferred Patents. Seller shall not, and shall cause its Subsidiaries not to, extend or enter into any new licenses or covenants not to assert with respect to the Transferred Patents.
Transferred Patents. The following Transferred Patents are transferred hereunder with respect to Coulter's 100% undivided interest therein: COUNTRY APP. NO./FXXXXX XXXE PATENT NO./ISSUE DATE STATUS ------- ----------------------- ---------------------- --------- US 08/918,525/ 21-Aug-1997 5,961,955/ 05-Oct-1999 Granted US 09/453,985/ 02-Dec-1999 6,338,835/ 15-Jan-2002 Granted US 60/048,387/ 03-Jun-1997 Converted WO US98/11428/ 03-Jun-1998 98/55154/ 10 Dec-1998 Converted AT 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted AU 80570/98/ 03-Jun-1998 743823/ 23-May-2002 Granted BE 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted CA 2,290,987/ 03-Jun-1998 Pending CH 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted CY 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted DE 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted DK 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted EP 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted ES 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted FI 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted FR 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted GB 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted GR 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted IE 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted COUNTRY APP. NO./FILING DATE PATENT NO./ISSUE DATE STATUS ------- ----------------------- ---------------------- --------- IL 133200/ 00-Xxx-0000 Xxxxxxx XX 00028875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted JP 11-502818/ 03-Jun-1998 02-516612/ 04-Jun-2002* Published LU 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted MC 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted NL 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted NO 1999 5906/ 03-Jun-1998 315-693/ 13-Oct-2003 Granted NZ 502029/ 03-Jun-1998 502029/ 04-Apr-2002 Granted PT 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted SE 98928875.8/ 03-Jun-1998 1003560/ 17-Sep-2003 Granted The following Transferred Patents are transferred hereunder with respect to Coulter's 50% undivided interest therein: COUNTRY APP. NO./FILXXX XXXX PATENT NO./ISSUE DATE STATUS THIRD PARTY INTEREST THIRD PARTY ------- ----------------------- ---------------------- --------- ----------------------- ---------------------- US 09/326,502/ 04-Jun-1999 Pending Co-owned; licensed back University of Michigan US 60/088,327/ 04-Jun-1998 Converted Co-owned; licensed back University of Michigan WO US99/12506/ 04-Jun-1999 99/62565/ 09-Dec-1999 Converted Co-owned; licensed back Unive...
Transferred Patents. Section 1.1(h)
